Each organisation appears once in this segment chart. Category counts include nine records with more than one role.
UAE Diagnostics Ecosystem Nexus
Interactive view loads when you reach this section.
UAE Diagnostics Investor ↔ Company Capital Links
Interactive view loads when you reach this section.
Connected information
Organisation profiles connect to leaders, capital and parent references, hubs, initiatives and clinical-trial participation where the source names can be matched.
98 international benchmark profiles and 28 benchmark deal records remain available in the existing intelligence tools. They are separate from the imported database totals.
16 supplementary organisation records from the earlier platform are retained under All markets.
Discover the organisations shaping diagnostics in the UAE. Follow the connections between clinics, labs, technology and capital, then explore the profiles behind them.
Standard access · Clinical recommendations pending medical validation.
Your context first
Only relevant questions
LIFE-STAGE PACKAGES
Every chapter deserves a little clarity.
Planning a family, navigating midlife or training for your next goal? Explore the assessments to discuss, and understand each biomarker before your review.
Free catalogue · Personalisation with Standard access
An inherited heart-risk factor. Test it once in your life.
Biomarker guide
Know what a test is for before you book it.
Plain-language pages for 232 lab tests, scans and body measures: what each one shows, who needs it, how to prepare, what it costs in the UAE, and whether the science is solid, emerging or a myth.
Evidence label on every testSo popular tests like epigenetic age or IgG food panels are put in context.
Normal and optimal rangesWhat “normal” means, and where an optimal target exists.
Prepared for the GulfFasting and Ramadan tips, regional risks, UAE prices and insurance.
232 entries · 27 categories · 132 sources · Preparation, reference records and glossary connected. Free access; medical review pending.
Products
What you can use, product by product.
Every product runs on the same audited database. Start free and add products as your work needs them.
Free clinical tools
Market at a glance
Three views worth seeing first.
Straight from the UAE Diagnostics Marketplace Intelligence Database. The full, interactive versions are inside the platform.
Organisations by type471 organisations, counted once
Clinics173
Investors77
Diagnostic labs68
Tech platforms55
Companies47
Research centres36
Clinical trials by start year214 registry trials, 2016 to 2026
316
817
1218
1019
2120
2321
1822
3523
2324
3025
2826
Where investors come from77 investors and parent groups
United Arab Emirates45
United States6
Switzerland3
United Kingdom3
Egypt2
Other countries18
Visual intelligence
Five live views, inside the platform.
The ecosystem map, the investor network, the opportunity matrix and the clinical trials views are part of the platform. Enter it to explore them with the full database.
Plans & pricing
Start free. Upgrade when you need more.
Choose the access level that fits your workflow, from free exploration to enterprise delivery.
Free
€0
Free forever
For individuals.
Lab and clinic directory and map
Biomarker sheets and pre-test guide
Life-stage packages and Gulf panels
Basic organisation profiles
Standard
€49/mo
Billed monthly
For individuals, analysts and small clinics.
Personal checklist, preparation and reference context
Results explainer and risk calculators
Full profiles with licence and accreditation
Advanced filters
Pro
€499/mo
Billed monthly
Self-service tools for one analyst.
Partner and distributor finder
Lead lists with verified contacts
Market monitor and alerts
Test intelligence and CSV export
Enterprise
€999/mo
Billed monthly
Tools plus intelligence done for your team · up to 10 users.
Lab due diligence and M&A targets
UAE market entry report and analyst call
Partner matchmaking and market sizing
API, white-label and account manager
The Intelligence Layer for Longevity Diagnostics
One connected workspace for providers, tests, owners, deals, regulatory facts and the UAE and Swiss markets.